384 related articles for article (PubMed ID: 4025686)
21. Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro.
McLaren DJ; McKean JR; Olsson I; Venges P; Kay AB
Parasite Immunol; 1981; 3(4):359-73. PubMed ID: 7322615
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.
Maddox DE; Butterfield JH; Ackerman SJ; Coulam CB; Gleich GJ
J Exp Med; 1983 Oct; 158(4):1211-26. PubMed ID: 6619734
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil- and eosinophil granule-mediated pneumocyte injury.
Ayars GH; Altman LC; Gleich GJ; Loegering DA; Baker CB
J Allergy Clin Immunol; 1985 Oct; 76(4):595-604. PubMed ID: 4056248
[TBL] [Abstract][Full Text] [Related]
24. Comparative toxicity of the horse eosinophil peroxidase-H2O2-halide system and granule basic proteins.
Klebanoff SJ; Agosti JM; Jörg A; Waltersdorph AM
J Immunol; 1989 Jul; 143(1):239-44. PubMed ID: 2659666
[TBL] [Abstract][Full Text] [Related]
25. Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis.
Tischendorf FW; Brattig NW; Burchard GD; Kubica T; Kreuzpaintner G; Lintzel M
Acta Trop; 1999 Mar; 72(2):157-73. PubMed ID: 10206116
[TBL] [Abstract][Full Text] [Related]
26. Eosinophils and cellular injury: the Gordon phenomenon as a model.
Fredens K; Dahl R; Venge P
N Engl Reg Allergy Proc; 1985; 6(4):346-51. PubMed ID: 3916590
[TBL] [Abstract][Full Text] [Related]
27. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization.
Davis MD; Plager DA; George TJ; Weiss EA; Gleich GJ; Leiferman KM
J Allergy Clin Immunol; 2003 Nov; 112(5):988-94. PubMed ID: 14610493
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes.
Tischendorf FW; Brattig NW; Büttner DW; Pieper A; Lintzel M
Acta Trop; 1996 Dec; 62(3):171-82. PubMed ID: 9025985
[TBL] [Abstract][Full Text] [Related]
29. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy.
Peters MS; Rodriguez M; Gleich GJ
Lab Invest; 1986 Jun; 54(6):656-62. PubMed ID: 3520144
[TBL] [Abstract][Full Text] [Related]
30. Eosinophil activity in bronchial asthma.
Venge P
Allergy Proc; 1994; 15(3):139-41. PubMed ID: 7926713
[TBL] [Abstract][Full Text] [Related]
31. Partial purification and biological properties of an eosinophil-activating factor.
Thorne KJ; Richardson BA; Veith MC; Tai PC; Spry CJ; Butterworth AE
Eur J Immunol; 1985 Nov; 15(11):1083-91. PubMed ID: 2998804
[TBL] [Abstract][Full Text] [Related]
32. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay.
Reimert CM; Venge P; Kharazmi A; Bendtzen K
J Immunol Methods; 1991 Apr; 138(2):285-90. PubMed ID: 2033280
[TBL] [Abstract][Full Text] [Related]
33. Eosinophil ribonucleases and their cutaneous lesion-forming activity.
Plager DA; Davis MD; Andrews AG; Coenen MJ; George TJ; Gleich GJ; Leiferman KM
J Immunol; 2009 Sep; 183(6):4013-20. PubMed ID: 19717523
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of a new cationic protein--eosinophil protein-X (EPX)--from granules of human eosinophils.
Peterson CG; Venge P
Immunology; 1983 Sep; 50(1):19-26. PubMed ID: 6885110
[TBL] [Abstract][Full Text] [Related]
35. Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein.
Kierszenbaum F; Ackerman SJ; Gleich GJ
Am J Trop Med Hyg; 1981 Jul; 30(4):775-9. PubMed ID: 7020455
[TBL] [Abstract][Full Text] [Related]
36. Schistosoma mansoni: further studies of the interaction between schistosomula and granulocyte-derived cationic proteins in vitro.
McLaren DJ; Peterson CG; Venge P
Parasitology; 1984 Jun; 88 ( Pt 3)():491-503. PubMed ID: 6739134
[TBL] [Abstract][Full Text] [Related]
37. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch.
Minnicozzi M; Durán WN; Gleich GJ; Egan RW
J Immunol; 1994 Sep; 153(6):2664-70. PubMed ID: 7521368
[TBL] [Abstract][Full Text] [Related]
38. Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein.
Slifman NR; Venge P; Peterson CG; McKean DJ; Gleich GJ
J Immunol; 1989 Oct; 143(7):2317-22. PubMed ID: 2506283
[TBL] [Abstract][Full Text] [Related]
39. Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins.
Makiya MA; Herrick JA; Khoury P; Prussin CP; Nutman TB; Klion AD
J Immunol Methods; 2014 Sep; 411():11-22. PubMed ID: 24914990
[TBL] [Abstract][Full Text] [Related]
40. [Eosinophil granule proteins (MBP, ECP, EPX/EDN, EPO)--a possible process of eosinophil activation and degranulation].
Tsuda S; Miyasato M
Nihon Rinsho; 1993 Mar; 51(3):613-9. PubMed ID: 8492433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
